Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer’s disease neuropathological deficits

1. Insights Into the Therapeutic Potential of SIRT1-modifying Compounds for Alzheimer’s Disease: A Focus on Molecular Mechanisms

   Dhyauldeen Aftan Al-Hayani, Aziz Kubaev, Subasini Uthirapathy +7

   Шарҳ мақолаSirtuins and Resveratrol in MedicineJournal of Molecular Neuroscience20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000029

2. Regulation of Apoptotic Pathways by MicroRNAs: A Therapeutic Strategy for Alzheimer’s Disease

   Mohamed J. Saadh, Faris Anad Muhammad, Tuqa S. Alazzawi +5

   Шарҳ мақолаMicroRNA in disease regulationMolecular Neurobiology20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000090